1-6 of 6
Man Mohan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression

Available to Purchase
Xufeng Lu, Dazhuan E. Xin, Juanjuan K. Du, Quanli C. Zou, Qian Wu, Yanan S. Zhang, Wenhai Deng, Jicheng Yue, Xing S. Fan, Yuanyuan Zeng, Xiaju Cheng, Xue Li, Zhaoyuan Hou, Man Mohan, Ting C. Zhao, Xiaomei Lu, Zhijie Chang, Liyan Xu, Yu Sun, Xiongbing Zu, Yu Zhang, Y. Eugene Chinn
Journal: Cancer Research
Cancer Res (2022) 82 (23): 4400–4413.
https://doi.org/10.1158/0008-5472.CAN-22-0848
Published: 02 December 2022
View articletitled, Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Open the PDF for Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression in another window
Includes: Supplementary data
Journal Articles

Abstract 3862: Ormeloxifene, a novel pharmacological activator of PKD1 enhances docetaxel sensitivity in prostate cancer

Free
Aditya Ganju, Bilal Bin Hafeez, Fathi Halaweish, Wei Li, Man Mohan Singh, Murali Mohan Yallapu, Subhash Chauhan, Meena Jaggi
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3862.
https://doi.org/10.1158/1538-7445.AM2016-3862
Published: 15 July 2016
View articletitled, Abstract 3862: Ormeloxifene, a novel pharmacological activator of PKD1 enhances docetaxel sensitivity in prostate cancer
Journal Articles

Abstract 2072: Ormeloxifene attenuates wnt/β-catenin signaling in colon cancer cells by modulation of PKD1 and glycolytic pathways

Free
Aditya Ganju, Rishi Gara, Sonam Kumari, Man Mohan Singh, Subhash Chauhan, Meena Jaggi
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2072.
https://doi.org/10.1158/1538-7445.AM2015-2072
Published: 01 August 2015
View articletitled, Abstract 2072: Ormeloxifene attenuates wnt/β-catenin signaling in colon cancer cells by modulation of PKD1 and glycolytic pathways
Journal Articles

Ormeloxifene Suppresses Desmoplasia and Enhances Sensitivity of Gemcitabine in Pancreatic Cancer

Free
Sheema Khan, Mara C. Ebeling, Neeraj Chauhan, Paul A. Thompson, Rishi K. Gara, Aditya Ganju, Murali M. Yallapu, Stephen W. Behrman, Haotian Zhao, Nadeem Zafar, Man Mohan Singh, Meena Jaggi, Subhash C. Chauhan
Journal: Cancer Research
Cancer Res (2015) 75 (11): 2292–2304.
https://doi.org/10.1158/0008-5472.CAN-14-2397
Published: 31 May 2015
View articletitled, Ormeloxifene Suppresses Desmoplasia and Enhances Sensitivity of Gemcitabine in Pancreatic Cancer
Open the PDF for Ormeloxifene Suppresses Desmoplasia and Enhances Sensitivity of Gemcitabine in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 1032: Ormeloxifene attenuates metastatic and glycolytic pathways in breast cancer cells

Free
Aditya Ganju, Vasudha Sundram, Keith Miskimins, Rishi Gara, Sheema Khan, Man Mohan Singh, Subhash C. Chauhan, Meena Jaggi
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1032.
https://doi.org/10.1158/1538-7445.AM2014-1032
Published: 01 October 2014
View articletitled, Abstract 1032: Ormeloxifene attenuates metastatic and glycolytic pathways in breast cancer cells
Journal Articles

Abstract 5500: Ormeloxifene modulates beta-catenin/TCF pathway in colon cancer.

Free
Vasudha Sundram, Rishi Kumar Gara, Man Mohan Singh, Subhash C. Chauhan, Meena Jaggi
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5500.
https://doi.org/10.1158/1538-7445.AM2013-5500
Published: 15 April 2013
View articletitled, Abstract 5500: Ormeloxifene modulates beta-catenin/TCF pathway in colon cancer.